ASX CODE: BDA

Bod Australia ASX BDA medicinal cannabis product clinical trial Phase 1

Clinical trial highlights tolerability of Bod Australia’s medicinal cannabis product

A phase one clinical trial of a sublingual cannabis wafer developed by Bod Australia (ASX: BDA) has highlighted the tolerability and superiority of the...
Bod Australia ASX BDA MediCabilis record sales revenue December 2018 quarter

Bod Australia posts record quarterly revenue thanks to new products, distribution deals

Skincare and health products developer Bod Australia (ASX: BDA) has posted a record revenue of $1.22 million for the last quarter of 2018, underpinned...
Bod Australia ASX BDA medicinal cannabis wafer export licence

Bod Australia gets green light to export growing medicinal cannabis product range

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has received the green light to export its patented sublingual form of medicinal cannabis after...
Chemist Warehouse Bod Australia ASX BDA MediCabilis medicinal cannabis

Chemist Warehouse adds Bod Australia’s cannabis oil MediCabilis to its shelves

Australia’s adoption of medicinal cannabis has taken another step forward after Bod Australia (ASX: BDA) announced it has begun dispensing MediCabilis, its proprietary cannabis...
Cannabis Access Clinics Australia medical research price analysis

Cannabis Access Clinics looks to aid Australian patient access to medical cannabis

The theory behind medical cannabis is that it has the potential to soothe many of today’s ailments, with illnesses such as epilepsy, multiple sclerosis...
Bod Australia ASX BDA CBD trial cannabidiol ECs315 cannabis extract clinical trial

Bod Australia hits major milestone in cannabis wafer trial

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has achieved what it calls a “world-first” in the clinical trial of its proprietary phytocomplex...
Bod Australia ASX BDA phase 1 clinical trial phytocomplex cannabis extract

Bod Australia kicks off phase 1 clinical trial for phytocomplex cannabis extract

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has stormed into a phase 1 clinical trial to test the safety, tolerability and pharmacokinetics of Bod’s...
Bod Australia ASX BDA Swisse director George Livery

Bod Australia recruits Swisse director alongside growing medical cannabis trend

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has appointed a new executive chairman to spearhead its multifaceted growth spurt in both natural medicines, but also,...
Bod Australia ASX BDA cannabis clinical trial approval

Bod Australia receives early green light to commence cannabis clinical trial

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has surprised the market by announcing that it has secured ethics approval in a record time of six...
Bod Australia ASX BDA MediCabilis medicinal cannabis oil

Bod Australia sets the stage for marketing medical cannabis oil in Australia

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added yet another string to its commercial bow, by completing its first order for...
Bod Australia ASX BDA Australian Pharmaceuticals Industries medicinal cannabis

Bod Australia obtains improved place in shop window via Australian Pharmaceuticals Industries

One of Australia’s emergent developer and distributors of cosmetics and natural medicines, Bod Australia (ASX: BDA) has secured potentially better marketability and market exposure,...
Bod Australia ASX BDA import medicinal cannabis oil

Bod Australia gains approval to commence importing medicinal cannabis oil

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added another piece to its puzzle towards commencing production of medicinal cannabis-based products in...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS